Oral pathogen aggravates atherosclerosis by inducing smooth muscle cell apoptosis and repressing macrophage efferocytosis
暂无分享,去创建一个
Rongyao Xu | Hongbing Jiang | Kai Zheng | Hanyu Xie | X. Ge | Laikui Liu | Shuyu Guo | Z. Ling | Ziyue Qin | Hang Zhang
[1] F. Zhan,et al. Macrophages: A communication network linking Porphyromonas gingivalis infection and associated systemic diseases , 2022, Frontiers in Immunology.
[2] D. Santovito,et al. Non-canonical features of microRNAs: paradigms emerging from cardiovascular disease , 2022, Nature Reviews Cardiology.
[3] A. Sculean,et al. Periodontal microorganisms and Alzheimer disease – A causative relationship? , 2022, Periodontology 2000.
[4] M. Gutierrez,et al. A sandPIT for Salmonella to play with efferosomes. , 2022, Cell host & microbe.
[5] Bin Liu,et al. Artemisinin and Procyanidins loaded multifunctional nanocomplexes alleviate atherosclerosis via simultaneously modulating lipid influx and cholesterol efflux. , 2021, Journal of controlled release : official journal of the Controlled Release Society.
[6] M. Reilly,et al. Long Noncoding RNA MIAT Controls Advanced Atherosclerotic Lesion Formation and Plaque Destabilization , 2021, Circulation.
[7] Yan Jin,et al. Apoptotic vesicles restore liver macrophage homeostasis to counteract type 2 diabetes , 2021, Journal of extracellular vesicles.
[8] Yu Fu,et al. Identification of the canonical and noncanonical role of miR-143/145 in estrogen-deficient bone loss , 2021, Theranostics.
[9] Guixue Wang,et al. Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications , 2021, Theranostics.
[10] Richard G. Lee,et al. RIPK1 Expression Associates with Inflammation in Early Atherosclerosis in Humans and Can be Therapeutically Silenced to Reduce NF-κB Activation and Atherogenesis in Mice. , 2020, Circulation.
[11] C. Varol,et al. Phenotype and Response to PAMPs of Human Monocyte-Derived Foam Cells Obtained by Long-Term Culture in the Presence of oxLDLs , 2020, Frontiers in Immunology.
[12] K. Buhlin,et al. Periodontal diseases and association with atherosclerotic disease. , 2020, Periodontology 2000.
[13] H. Chung,et al. Catechin ameliorates Porphyromonas gingivalis-induced inflammation via the regulation of TLR2/4 and inflammasome signaling. , 2020, Journal of periodontology.
[14] Q. Tang,et al. BMAL1-Downregulation Aggravates Porphyromonas Gingivalis-Induced Atherosclerosis by Encouraging Oxidative Stress , 2020, Circulation research.
[15] Xiang-Dong Fu,et al. Nuclear miR-320 Mediates Diabetes-Induced Cardiac Dysfunction by Activating Transcription of Fatty Acid Metabolic Genes to Cause Lipotoxicity in the Heart , 2019, Circulation research.
[16] Clare M. Waterman,et al. Coupling of β2 integrins to actin by a mechanosensitive molecular clutch drives complement receptor-mediated phagocytosis , 2019, Nature Cell Biology.
[17] C. Cutler,et al. Disruption of Immune Homeostasis in Human Dendritic Cells via Regulation of Autophagy and Apoptosis by Porphyromonas gingivalis , 2019, Front. Immunol..
[18] Rachel E. Brewer,et al. CD24 signalling through macrophage Siglec-10 is a new target for cancer immunotherapy , 2019, Nature.
[19] Liwu Li,et al. Novel reprogramming of neutrophils modulates inflammation resolution during atherosclerosis , 2019, Science Advances.
[20] Yanbing Zhao,et al. Pretreated Macrophage‐Membrane‐Coated Gold Nanocages for Precise Drug Delivery for Treatment of Bacterial Infections , 2018, Advanced materials.
[21] D. Green,et al. LC3-Associated Phagocytosis in Myeloid Cells Promotes Tumor Immune Tolerance , 2018, Cell.
[22] T. Kurita-Ochiai,et al. Porphyromonas gingivalis Induces Apoptosis and Autophagy via ER Stress in Human Umbilical Vein Endothelial Cells , 2018, Mediators of inflammation.
[23] I. Tabas,et al. The role of non‐resolving inflammation in atherosclerosis , 2018, The Journal of clinical investigation.
[24] D. Nam,et al. Apoptotic Cell-Derived Extracellular Vesicles Promote Malignancy of Glioblastoma Via Intercellular Transfer of Splicing Factors. , 2018, Cancer cell.
[25] A. Stark,et al. Eukaryotic core promoters and the functional basis of transcription initiation , 2018, Nature Reviews Molecular Cell Biology.
[26] M. Delgado-Rodríguez,et al. Systematic review and meta-analysis. , 2017, Medicina intensiva.
[27] N. Benkirane-Jessel,et al. Porphyromonas gingivalis Differentially Modulates Apoptosome Apoptotic Peptidase Activating Factor 1 in Epithelial Cells and Fibroblasts. , 2017, The American journal of pathology.
[28] N. Walter,et al. Resolving Subcellular miRNA Trafficking and Turnover at Single-Molecule Resolution. , 2017, Cell reports.
[29] E. Morselli,et al. The effects of oestrogens and their receptors on cardiometabolic health , 2017, Nature Reviews Endocrinology.
[30] M. Cheetham,et al. The multimorbidity interaction severity index (MISI) , 2017, Medicine.
[31] S. Amar,et al. Identification and Characterization of MicroRNA Differentially Expressed in Macrophages Exposed to Porphyromonas gingivalis Infection , 2017, Infection and Immunity.
[32] Jens-Peter Volkmer,et al. CD47 blocking antibodies restore phagocytosis and prevent atherosclerosis , 2016, Nature.
[33] D. Tsiantoulas,et al. Sialic Acid-Binding Immunoglobulin-like Lectin G Promotes Atherosclerosis and Liver Inflammation by Suppressing the Protective Functions of B-1 Cells , 2016, Cell reports.
[34] Y. Lai,et al. Staphylococcal LTA-Induced miR-143 Inhibits Propionibacterium acnes-Mediated Inflammatory Response in Skin. , 2016, The Journal of investigative dermatology.
[35] Bor-Shiunn Lee,et al. Controlled-release of tetracycline and lovastatin by poly(d,l-lactide-co-glycolide acid)-chitosan nanoparticles enhances periodontal regeneration in dogs , 2016, International journal of nanomedicine.
[36] G. Hajishengallis,et al. Periodontitis: from microbial immune subversion to systemic inflammation , 2014, Nature Reviews Immunology.
[37] Guocheng Yuan,et al. LincRNA-p21 Regulates Neointima Formation, Vascular Smooth Muscle Cell Proliferation, Apoptosis, and Atherosclerosis by Enhancing p53 Activity , 2014, Circulation.
[38] G. Condorelli,et al. MiR-143/145 deficiency attenuates the progression of atherosclerosis in Ldlr-/- mice , 2014, Thrombosis and Haemostasis.
[39] J. Hamilton,et al. Distinct Lipid A Moieties Contribute to Pathogen-Induced Site-Specific Vascular Inflammation , 2014, PLoS pathogens.
[40] John D Lambris,et al. Porphyromonas gingivalis manipulates complement and TLR signaling to uncouple bacterial clearance from inflammation and promote dysbiosis. , 2014, Cell host & microbe.
[41] C. Cutler,et al. Secondary Lymphoid Organ Homing Phenotype of Human Myeloid Dendritic Cells Disrupted by an Intracellular Oral Pathogen , 2013, Infection and Immunity.
[42] C. Cutler,et al. Microbial Carriage State of Peripheral Blood Dendritic Cells (DCs) in Chronic Periodontitis Influences DC Differentiation, Atherogenic Potential , 2012, The Journal of Immunology.
[43] N. Bostanci,et al. Porphyromonas gingivalis: an invasive and evasive opportunistic oral pathogen. , 2012, FEMS microbiology letters.
[44] Haitao Wen,et al. Porphyromonas gingivalis Mediates Inflammasome Repression in Polymicrobial Cultures through a Novel Mechanism Involving Reduced Endocytosis* , 2012, The Journal of Biological Chemistry.
[45] Achilleas S. Frangakis,et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs , 2012, Nature Cell Biology.
[46] Antonio Marchetti,et al. A Unique MicroRNA Signature Associated With Plaque Instability in Humans , 2011, Stroke.
[47] S. Akira,et al. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. , 2011, Immunity.
[48] L. Shapira,et al. How has neutrophil research improved our understanding of periodontal pathogenesis? , 2011, Journal of clinical periodontology.
[49] Shuming Nie,et al. Understanding and overcoming major barriers in cancer nanomedicine. , 2010, Nanomedicine.
[50] John D Lambris,et al. Microbial Hijacking of Complement–Toll-Like Receptor Crosstalk , 2010, Science Signaling.
[51] D. Weigel,et al. Transcriptional Control of Gene Expression by MicroRNAs , 2010, Cell.
[52] P. Siegl,et al. Periodontitis and atherosclerotic cardiovascular disease , 2009, BDJ.
[53] Chunxiang Zhang. MicroRNA and vascular smooth muscle cell phenotype: new therapy for atherosclerosis? , 2009, Genome Medicine.
[54] Deepak Srivastava,et al. miR-145 and miR-143 Regulate Smooth Muscle Cell Fate Decisions , 2009, Nature.
[55] P. Libby,et al. The American Journal of Cardiology and Journal of Periodontology editors' consensus: periodontitis and atherosclerotic cardiovascular disease. , 2009, Journal of periodontology.
[56] P. Libby,et al. The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: periodontitis and atherosclerotic cardiovascular disease. , 2009, The American journal of cardiology.
[57] Yang Liu,et al. CD24 and Siglec-10 Selectively Repress Tissue Damage–Induced Immune Responses , 2009, Science.
[58] D. Couper,et al. Results from the Periodontitis and Vascular Events (PAVE) Study: a pilot multicentered, randomized, controlled trial to study effects of periodontal therapy in a secondary prevention model of cardiovascular disease. , 2009, Journal of periodontology.
[59] P. Sætrom,et al. MicroRNA-directed transcriptional gene silencing in mammalian cells , 2008, Proceedings of the National Academy of Sciences.
[60] J. Parsons,et al. Regulation of lamellipodial persistence, adhesion turnover, and motility in macrophages by focal adhesion kinase , 2007, The Journal of cell biology.
[61] Ozlem Yilmaz,et al. Intrinsic apoptotic pathways of gingival epithelial cells modulated by Porphyromonas gingivalis , 2007, Cellular microbiology.
[62] Chunxiang Zhang,et al. MicroRNA Expression Signature and Antisense-Mediated Depletion Reveal an Essential Role of MicroRNA in Vascular Neointimal Lesion Formation , 2007, Circulation research.
[63] Francesco D'Aiuto,et al. Treatment of periodontitis and endothelial function. , 2007, The New England journal of medicine.
[64] S. Uriarte,et al. Porphyromonas gingivalis enhances FasL expression via up-regulation of NFkappaB-mediated gene transcription and induces apoptotic cell death in human gingival epithelial cells. , 2006, Microbiology.
[65] Philip J. Barter,et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. , 2005, The New England journal of medicine.
[66] M. Trevisan,et al. Identification of periodontal pathogens in atheromatous plaques. , 2000, Journal of periodontology.
[67] D. E. Slot,et al. Treatment of periodontitis improves the atherosclerotic profile: a systematic review and meta-analysis. , 2014, Journal of clinical periodontology.
[68] P. Libby,et al. ’ Consensus : Periodontitis and Atherosclerotic Cardiovascular Disease † , 2009 .
[69] Gerardo Maupome,et al. Results From the Periodontitis and Vascular Events ( PAVE ) Study : A Pilot Multicentered , Randomized , Controlled Trial to Study Effects of Periodontal Therapy in a Secondary Prevention Model of Cardiovascular Disease , 2009 .
[70] A. Zeiher,et al. Apoptosis in the vascular wall and atherosclerosis , 2001, Basic Research in Cardiology.